Christopher Chipman
2020
In 2020, Christopher Chipman earned a total compensation of $276K as Chief Financial Officer at Virpax Pharmaceuticals.
Compensation breakdown
| Option Awards | $228,000 |
|---|---|
| Salary | $48,000 |
| Total | $276,000 |
Chipman received $228K in option awards, accounting for 83% of the total pay in 2020.
Chipman also received $48K in salary.
Rankings
In 2020, Christopher Chipman's compensation ranked 12,231st out of 13,090 executives tracked by ExecPay. In other words, Chipman earned more than 6.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,231 out of 13,090 | 7th |
Division Manufacturing | 5,240 out of 5,621 | 7th |
Major group Chemicals And Allied Products | 2,128 out of 2,254 | 6th |
Industry group Drugs | 1,850 out of 1,954 | 5th |
Industry Pharmaceutical Preparations | 1,373 out of 1,459 | 6th |
Source: SEC filing on June 15, 2022.
Chipman's colleagues
We found two more compensation records of executives who worked with Christopher Chipman at Virpax Pharmaceuticals in 2020.